TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pfizer Anti-Infectives AB
Closing information (x1000 DKK)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
1,182,608
|
1,379,535
|
921,047 |
| Financial expenses |
0
|
0
|
321 |
| Earnings before taxes |
701,736
|
659,121
|
282,578 |
| EBITDA |
659,432
|
680,139
|
323,188 |
| Total assets |
1,863,575
|
1,639,273
|
1,075,813 |
| Current assets |
63,828
|
43,431
|
76,473 |
| Current liabilities |
168,171
|
493,133
|
425,854 |
| Equity capital |
1,695,404
|
1,146,141
|
649,959 |
| - share capital |
32
|
33
|
34 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
91.0%
|
69.9%
|
60.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
59.3%
|
47.8%
|
30.7% |
| Return on assets (ROA) |
37.7%
|
40.2%
|
26.3% |
| Current ratio |
38.0%
|
8.8%
|
18.0% |
| Return on equity (ROE) |
41.4%
|
57.5%
|
43.5% |
| Change turnover |
-187,052
|
496,983
|
696,089 |
| Change turnover % |
-14%
|
56%
|
309% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.